Contemporary Management of HIV: Integrating New Data From Fall 2019 HIV Conferences

In this downloadable slideset, review key HIV data from the 2019 IDWeek and EACS meetings on PrEP outcomes, ART efficacy and tolerability in first-line and switch settings, metabolic and weight considerations with HIV therapy, and regimen selection during pregnancy.
Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
David A. Wohl, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 699 KB
Released: December 5, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
ViiV Healthcare

Related Content

Expert selections of the most important new data from HIV Glasgow 2020, including current and investigational ART, and more, from CCO

Monica Gandhi, MD, MPH Renslow Sherer, MD Released: October 23, 2020

Short video log from Dr. Howard Grossman on initiating gender-affirming hormone therapy in a transgender woman with virologically suppressed HIV

Howard Grossman, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: October 22, 2020 Expired: October 21, 2021

Expert panel discussion of the latest ART advances, including 2-drug therapy, safety in pregnancy, weight gain, and forthcoming innovations

CCO video: Drs. Lisa Fitzpatrick and David Malebranche on ending the HIV epidemic by improving testing, care linkage, and outbreak response in the US

Lisa K. Fitzpatrick, MD, MPH, MPA David Malebranche, MD, MPH Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Physician Assistants: maximum of 0.75 hours of AAPA Category I CME credits Released: October 22, 2020 Expired: October 21, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue